SCM
TMO icon

Segantii Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Segantii Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50,000
Closed -$9.46M – 59
2017
Q3 		$9.46M Buy
+50,000
New +$9.06M 3.7% 9

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Segantii Capital Management's TMO Position: Q4 2017 in Review

Segantii Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2017, closing a stake of 50,000 shares — an estimated $9.46M sold.

Segantii Capital Management first reported a position in TMO in Q3 2017 and held it in 1 quarter. The position peaked at $9.46M in Q3 2017. 1,246 funds tracked by Wall St. Rank hold TMO as of Q4 2017.

  • Segantii Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2017 after selling out during the quarter.
  • Segantii Capital Management sold 50,000 Thermo Fisher Scientific shares in Q4 2017, an estimated $9.46M.
  • Segantii Capital Management first reported a position in Thermo Fisher Scientific in Q3 2017 and held it in 1 quarter.
  • Segantii Capital Management's Thermo Fisher Scientific position peaked at $9.46M in Q3 2017.
  • 1,246 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2017.

Based on Segantii Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.